세계의 세포 분리 시장 규모, 점유율, 동향 분석 보고서 : 세포 유형별, 제품별, 기술별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Cell Separation Market Summary

The global cell separation market size was estimated at USD 9.64 billion in 2024 and is projected to reach USD 23.16 billion by 2033, growing at a CAGR of 10.55% from 2025 to 2033. Cell separation plays an important role in various applications, including biologics designing and development, therapeutic protein production, in vitro diagnostics, and other research applications.

Rising prevalence of chronic and infectious diseases, such as cancer and COVID-19, along with continuous government initiatives to improve the biotechnology industry, are the major factors contributing to market growth. Product innovation is one of the key growth determinants of the market. Various companies, such as NanoString Technologies, Levitas Bio, and Bionano Genomics, have undertaken product development strategies and expanded their offering. For instance, in April 2022, Levitas Bio announced the launch of the LeviCell EOS System, their next-generation platform for cell separation. The new product enables a targeted selection of viable cells and has a relatively higher throughput than the company's existing products. In addition, the COVID-19 pandemic has provided researchers with an opportunity to investigate and comprehend this novel infectious virus and to discover therapies and diagnostic aids for it.

For instance, in March 2020, the U.S. President signed an emergency spending bill, wherein USD 3 billion is accounted to be used for the R&D of vaccines, medical treatments, and test kits. This has significantly boosted the demand for cell separation tools in research applications.Cell separation or isolation techniques are widely used to develop and manufacture biologics, such as monoclonal antibodies and recombinant proteins. These products have been gaining traction over the past few decades. With the substantial growth of specialty drugs and personalized medicine, the demand for biologics has been increasing. According to CAS (A division of the American Chemical Society), it was estimated that biologics will grow to USD 399.5 billion by 2025.

Moreover, the funding and current high demand have also motivated startups to enter the cell separation industry, despite the high cost of R&D. StartUs Insights identified and analyzed 957 startups in the field of cell and molecular biology solutions that are contributing to the sector growth. For instance, in October 2023, Veeda Group, in partnership with Atal Incubation Centre - Centre for Cellular and Molecular Biology (AIC - CCMB), newly introduced a half-day symposium in Hyderabad. The event, titled "Integrated Phase I Trial Solutions for Emerging Biopharmaceuticals: Addressing Development Challenges and Accelerating Timelines," focused on optimizing processes and overcoming challenges in the development of New Chemical Entities (NCEs) and Large Molecules. Furthermore, the growing prevalence of chronic diseases has increased the demand for diagnostic solutions and research applications.

As per the American Cancer Society, in 2023, in the U.S. alone, more than 1.9 million new cases of cancer are projected to be diagnosed. According to the WHO, 58 million people worldwide are suffering from chronic hepatitis C infection,with approximately 1.5 million new infections occurring every year.Instruments and related products can render accurate and effective results and have indispensable applications in the fields of disease diagnosis and scientific research. However, these products have high prices, which could, to some extent, restrict market growth. The techniques also involve a wide range of expenses for equipment, reagents, kits, sera, and services. The experimental setup and the reagents utilized for certain applications are pricey. These factors are anticipated to limit the cell separation industry's growth to a certain extent during the forecast period.

Global Cell Separation Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell separation market report based on product, cell type, technique, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Consumables
  • Reagents, Kits, Media, and Sera
  • Beads
  • Disposables
• Instruments
  • Centrifuges
  • Flow Cytometers
  • Filtration Systems
  • Magnetic-activated Cell Separator Systems
• Cell Type Outlook (Revenue, USD Million, 2021 - 2033)
• Human Cells
• Animal Cells
• Technique Outlook (Revenue, USD Million, 2021 - 2033)
• Centrifugation
• Surface Marker
• Filtration
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Biomolecule Isolation
• Cancer Research
• Stem Cell Research
• Tissue Regeneration
• In Vitro Diagnostics
• Therapeutics
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Research Laboratories and Institutes
• Hospitals and Diagnostic Laboratories
• Cell Banks
• Biotechnology and Biopharmaceutical Companies
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1 Product
    • 1.1.1.2 Cell Type
    • 1.1.1.3 Technique
    • 1.1.1.4 Application
    • 1.1.1.5 End Use
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information or Data Analysis:
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Cell Separation Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1 Rising demand for biopharmaceuticals
    • 3.3.1.2 Increasing government funding for cell-based research
    • 3.3.1.3 Growing focus on personalized medicine
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. High cost of cell isolation products
• 3.4. Cell Separation Market Analysis Tools
  • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.4.2. Porter's Five Forces Analysis
  • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Cell Separation Market: Product Business Analysis

• 4.1. Segment Dashboard
• 4.2. Cell Separation Market: Product Movement Analysis
• 4.3. Consumables
  • 4.3.1. CONSUMABLES MARKET, 2021 to 2033 (USD Million)
  • 4.3.2. Reagents, kits, media, and sera
    • 4.3.2.1. Reagents, kits, media, and sera Market, 2021 to 2033 (USD Million)
  • 4.3.3. Beads
    • 4.3.3.1. Beads Market, 2021 to 2033 (USD Million)
  • 4.3.4. Disposables
    • 4.3.4.1. Disposables Market, 2021 to 2033 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments Market, 2021 to 2033 (USD Million)
  • 4.4.2. Centrifuges
    • 4.4.2.1. Centrifuges Market, 2021 to 2033 (USD Million)
  • 4.4.3. Flow cytometers
    • 4.4.3.1. Flow cytometers Market, 2021 to 2033 (USD Million)
  • 4.4.4. Filtration systems
    • 4.4.4.1. Filtration Systems Market, 2021 to 2033 (USD Million)
  • 4.4.5. Magnetic-activated cell separator systems
    • 4.4.5.1. Magnetic-activated cell separator systems Market, 2021 to 2033 (USD Million)

Chapter 5. Cell Separation Market: Cell Type Business Analysis

• 5.1. Segment Dashboard
• 5.2. Cell Separation Market: Cell Type Movement Analysis
• 5.3. Human Cells
  • 5.3.1. Human Cells Market, 2021 to 2033 (USD Million)
• 5.4. Animal Cells
  • 5.4.1. Animal Cells Market, 2021 to 2033 (USD Million)

Chapter 6. Cell Separation Market: Technique Business Analysis

• 6.1. Segment Dashboard
• 6.2. Cell Separation Market: Technique Movement Analysis
• 6.3. Centrifugation
  • 6.3.1. Centrifugation Market, 2021 to 2033 (USD Million)
• 6.4. Surface Marker
  • 6.4.1. Surface Marker Market, 2021 to 2033 (USD Million)
• 6.5. Filtration
  • 6.5.1. Filtration Market, 2021 to 2033 (USD Million)

Chapter 7. Cell Separation Market: Application Business Analysis

• 7.1. Segment Dashboard
• 7.2. Cell Separation Market: Application Movement Analysis
• 7.3. Biomolecule Isolation
  • 7.3.1. Biomolecule Isolation Market, 2021 to 2033 (USD Million)
• 7.4. Cancer Research
  • 7.4.1. Cancer research Market, 2021 to 2033 (USD Million)
• 7.5. Stem Cell Research
  • 7.5.1. Stem cell research Market, 2021 to 2033 (USD Million)
• 7.6. Tissue Regeneration
  • 7.6.1. Tissue regeneration Market, 2021 to 2033 (USD Million)
• 7.7. In Vitro Diagnostics
  • 7.7.1. In vitro diagnostics Market, 2021 to 2033 (USD Million)
• 7.8. Therapeutics
  • 7.8.1. Therapeutics Market, 2021 to 2033 (USD Million)

Chapter 8. End Use Business Analysis

• 8.1. Segment Dashboard
• 8.2. Cell Separation Market: End Use Movement Analysis
• 8.3. Research Laboratories and Institutes
  • 8.3.1. Research laboratories and institutes Market, 2021 to 2033 (USD Million)
• 8.4. Hospitals and Diagnostic Laboratories
  • 8.4.1. Hospitals and diagnostic laboratories Market, 2021 to 2033 (USD Million)
• 8.5. Cell Banks
  • 8.5.1. Cell Banks Market, 2021 to 2033 (USD Million)
• 8.6. Biotechnology and Biopharmaceutical Companies
  • 8.6.1. Biotechnology and biopharmaceutical companies Market, 2021 to 2033 (USD Million)

Chapter 9. Cell Separation Market: Regional Business Analysis

• 9.1. Regional Dashboard
• 9.2. Cell Separation Market Share By Region, 2024 & 2033
  • 9.2.1. North America
    • 9.2.1.1. North America Market Size, & Forecasts and Trend Analysis, 2021 to 2033 (USD Million)
    • 9.2.1.2. U.S.
      • 9.2.1.2.1. Key Country Dynamics
      • 9.2.1.2.2. Competitive Scenario
      • 9.2.1.2.3. Regulatory Framework
      • 9.2.1.2.4. U.S. Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.1.3. Canada
      • 9.2.1.3.1. Key Country Dynamics
      • 9.2.1.3.2. Competitive Scenario
      • 9.2.1.3.3. Regulatory Framework
      • 9.2.1.3.4. Canada Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.1.4. Mexico
      • 9.2.1.4.1. Key Country Dynamics
      • 9.2.1.4.2. Competitive Scenario
      • 9.2.1.4.3. Regulatory Framework
      • 9.2.1.4.4. Mexico Cell Separation Market, 2021 to 2033 (USD Million)
  • 9.2.2. Europe
    • 9.2.2.1. Europe Market Size, & Forecasts and Trend Analysis, 2021 to 2033 (USD Million)
    • 9.2.2.2. UK
      • 9.2.2.2.1. Key Country Dynamics
      • 9.2.2.2.2. Competitive Scenario
      • 9.2.2.2.3. Regulatory Framework
      • 9.2.2.2.4. UK Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.2.3. Germany
      • 9.2.2.3.1. Key Country Dynamics
      • 9.2.2.3.2. Competitive Scenario
      • 9.2.2.3.3. Regulatory Framework
      • 9.2.2.3.4. Germany Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.2.4. France
      • 9.2.2.4.1. Key Country Dynamics
      • 9.2.2.4.2. Competitive Scenario
      • 9.2.2.4.3. Regulatory Framework
      • 9.2.2.4.4. France Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.2.5. Italy
      • 9.2.2.5.1. Key Country Dynamics
      • 9.2.2.5.2. Competitive Scenario
      • 9.2.2.5.3. Regulatory Framework
      • 9.2.2.5.4. Italy Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.2.6. Spain
      • 9.2.2.6.1. Key Country Dynamics
      • 9.2.2.6.2. Competitive Scenario
      • 9.2.2.6.3. Regulatory Framework
      • 9.2.2.6.4. Spain Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.2.7. Denmark
      • 9.2.2.7.1. Key Country Dynamics
      • 9.2.2.7.2. Competitive Scenario
      • 9.2.2.7.3. Regulatory Framework
      • 9.2.2.7.4. Denmark Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.2.8. Sweden
      • 9.2.2.8.1. Key Country Dynamics
      • 9.2.2.8.2. Competitive Scenario
      • 9.2.2.8.3. Regulatory Framework
      • 9.2.2.8.4. Sweden Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.2.9. Norway
      • 9.2.2.9.1. Key Country Dynamics
      • 9.2.2.9.2. Competitive Scenario
      • 9.2.2.9.3. Regulatory Framework
      • 9.2.2.9.4. Norway Cell Separation Market, 2021 to 2033 (USD Million)
  • 9.2.3. Asia Pacific
    • 9.2.3.1. Asia Pacific Market Size, & Forecasts and Trend Analysis, 2021 to 2033 (USD Million)
    • 9.2.3.2. Japan
      • 9.2.3.2.1. Key Country Dynamics
      • 9.2.3.2.2. Competitive Scenario
      • 9.2.3.2.3. Regulatory Framework
      • 9.2.3.2.4. Japan Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.3.3. China
      • 9.2.3.3.1. Key Country Dynamics
      • 9.2.3.3.2. Competitive Scenario
      • 9.2.3.3.3. Regulatory Framework
      • 9.2.3.3.4. China Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.3.4. India
      • 9.2.3.4.1. Key Country Dynamics
      • 9.2.3.4.2. Competitive Scenario
      • 9.2.3.4.3. Regulatory Framework
      • 9.2.3.4.4. India Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.3.5. South Korea
      • 9.2.3.5.1. Key Country Dynamics
      • 9.2.3.5.2. Competitive Scenario
      • 9.2.3.5.3. Regulatory Framework
      • 9.2.3.5.4. South Korea Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.3.6. Australia
      • 9.2.3.6.1. Key Country Dynamics
      • 9.2.3.6.2. Competitive Scenario
      • 9.2.3.6.3. Regulatory Framework
      • 9.2.3.6.4. Australia Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.3.7. Thailand
      • 9.2.3.7.1. Key Country Dynamics
      • 9.2.3.7.2. Competitive Scenario
      • 9.2.3.7.3. Regulatory Framework
      • 9.2.3.7.4. Thailand Cell Separation Market, 2021 to 2033 (USD Million)
  • 9.2.4. Latin America
    • 9.2.4.1. Latin America Market Size, & Forecasts and Trend Analysis, 2021 to 2033 (USD Million)
    • 9.2.4.2. Brazil
      • 9.2.4.2.1. Key Country Dynamics
      • 9.2.4.2.2. Competitive Scenario
      • 9.2.4.2.3. Regulatory Framework
      • 9.2.4.2.4. Brazil Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.4.3. Argentina
      • 9.2.4.3.1. Key Country Dynamics
      • 9.2.4.3.2. Competitive Scenario
      • 9.2.4.3.3. Regulatory Framework
      • 9.2.4.3.4. Argentina Cell Separation Market, 2021 to 2033 (USD Million)
  • 9.2.5. Middle East & Africa
    • 9.2.5.1. Middle East & Africa Market Size, & Forecasts and Trend Analysis, 2021 to 2033 (USD Million)
    • 9.2.5.2. South Africa
      • 9.2.5.2.1. Key Country Dynamics
      • 9.2.5.2.2. Competitive Scenario
      • 9.2.5.2.3. Regulatory Framework
      • 9.2.5.2.4. South Africa Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.5.3. Saudi Arabia
      • 9.2.5.3.1. Key Country Dynamics
      • 9.2.5.3.2. Competitive Scenario
      • 9.2.5.3.3. Regulatory Framework
      • 9.2.5.3.4. Saudi Arabia Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.5.4. UAE
      • 9.2.5.4.1. Key Country Dynamics
      • 9.2.5.4.2. Competitive Scenario
      • 9.2.5.4.3. Regulatory Framework
      • 9.2.5.4.4. UAE Cell Separation Market, 2021 to 2033 (USD Million)
    • 9.2.5.5. Kuwait
      • 9.2.5.5.1. Key Country Dynamics
      • 9.2.5.5.2. Competitive Scenario
      • 9.2.5.5.3. Regulatory Framework
      • 9.2.5.5.4. Kuwait Cell Separation Market, 2021 to 2033 (USD Million)

Chapter 10. Cell Separation Market: Company Profiles

• 10.1. Company Profiles
  • 10.1.1. Thermo Fisher Scientific, Inc.
    • 10.1.1.1. Company overview
    • 10.1.1.2. Financial Performance
    • 10.1.1.3. Product benchmarking
    • 10.1.1.4. Strategic initiatives
  • 10.1.2. Danaher
    • 10.1.2.1. Company overview
    • 10.1.2.2. Financial Performance
    • 10.1.2.3. Product benchmarking
    • 10.1.2.4. Strategic initiatives
  • 10.1.3. BD
    • 10.1.3.1. Company overview
    • 10.1.3.2. Financial Performance
    • 10.1.3.3. Product benchmarking
    • 10.1.3.4. Strategic initiatives
  • 10.1.4. Terumo Corporation
    • 10.1.4.1. Company overview
    • 10.1.4.2. Financial Performance
    • 10.1.4.3. Product benchmarking
    • 10.1.4.4. Strategic initiatives
  • 10.1.5. STEMCELL Technologies Inc.
    • 10.1.5.1. Company overview
    • 10.1.5.2. Financial Performance
    • 10.1.5.3. Product benchmarking
    • 10.1.5.4. Strategic initiatives
  • 10.1.6. Bio-Rad Laboratories, Inc.
    • 10.1.6.1. Company overview
    • 10.1.6.2. Financial Performance
    • 10.1.6.3. Product benchmarking
    • 10.1.6.4. Strategic initiatives
  • 10.1.7. Merck KGaA
    • 10.1.7.1. Company overview
    • 10.1.7.2. Financial Performance
    • 10.1.7.3. Product benchmarking
    • 10.1.7.4. Strategic initiatives
  • 10.1.8. Agilent Technologies, Inc.
    • 10.1.8.1. Company overview
    • 10.1.8.2. Financial Performance
    • 10.1.8.3. Product benchmarking
    • 10.1.8.4. Strategic initiatives
  • 10.1.9. Corning Inc.
    • 10.1.9.1. Company overview
    • 10.1.9.2. Financial Performance
    • 10.1.9.3. Product benchmarking
    • 10.1.9.4. Strategic initiatives
  • 10.1.10. Akadeum Life Sciences
    • 10.1.10.1. Company overview
    • 10.1.10.2. Financial Performance
    • 10.1.10.3. Product benchmarking
    • 10.1.10.4. Strategic initiatives